Questions
Summaries
Videos
Audios
What best describes disdiadochokinesis in the context of a neurological examination?
What does the “cogwheel sign” typically refer to in a clinical context?
What is nystagmus in the context of a neurological examination?
Which of the following statements best describes parkinsonism?
What does the mnemonic “DANISH” represent in the context of cerebellar disease assessment, and what do its components stand for?
Which features are typically associated with Parkinson’s syndrome, a neurological disorder that is characterized by motor symptoms?
What is typically observed in terms of deep tendon reflexes in individuals with basal ganglia lesions?
What substance is primarily associated with the development of Parkinson’s disease?
Коя от изброените структури не се отнася към екстрапирамидната система?
Which of the following is an example of a hyperkinetic extrapyramidal syndrome?
Мускулна хипотония може да се наблюдава при:
What best describes the characteristic features of ataxia?
Кое определение най-точно описва термина атаксия?
Кое е характерно за неоцеребеларния синдром?
Как се променя походката при церебеларна увреда?
Кои от изброените тестове се използват за оценка на координацията при снемане на неврологичен статус?
При теста на Ромберг пациентът залита с отворени и затворени очи. Каква е интерпретацията на теста?
Какъв е тестът на Ромберг при сензорна атаксия?
При изследване на координацията пациентът е помолен да докосне с върха на показалеца си върха на носа си с едната и след това с другата ръка. Първо с отворени, а след това със затворени очи. Как се нарича тази проба?
При носо-показалечна проба със затворени очи пациентът докосва дясното си око вместо върха на носа си. Как се нарича това?
Neurotransmission
Parkinson’s Disease Differential Diagnosis Questionnaire
Role of the Direct and Indirect Pathways in the Extrapyramidal System: Balancing Motor Control
The Unified Parkinson’s Disease Rating Scale (UPDRS)
Lewy Body Dementia with Parkinsonism versus Parkinson’s Disease
Aging as a Risk Factor for Parkinson’s Disease
The Role of Genetics in Parkinson’s Disease
Protective Factors for Parkinson’s Disease: Physical Activity, Smoking, and Caffeine
Alpha-Synuclein vs. Tau Protein: A Comparative Overview
Tau Protein
Alpha-Synuclein and α-Synucleinopathies
Genetics and Multiple Sclerosis
Etiology of Multiple Sclerosis
Differential Diagnosis for Parkinson’s Disease
Cauda Equina Syndrome (CES)
Brachial Plexus
Treatment Options for Multiple Sclerosis
Diet Recommendations for Patients with Multiple Sclerosis
Wallenberg Syndrome (Lateral Medullary Syndrome)
Circle of Willis
No videos found
Q 2.35. Emergencies in Neurology
Q 2.34. Dementia
Q 2.33. Headache
Q 2.32. Wilson’s Disease
Q 2.31. Chorea
Q 2.30. Progressive Muscular Dystrophy
Q 2.29. Spinal Muscular Atrophy
Q 2.28. Amyotrophic Lateral Sclerosis
Q 2.27. Parkinson’s Disease
Q 2.26. Status Epilepticus
Q 2.25. Epilepsy
Q 2.24. Traumatic Brain Injury
Q 2.23. Spinal Cord Tumors
Q 2.22. Cerebral Tumors
Q 2.21. Cerebral Vein and Dural Thrombosis
Q 2.20. Subarachnoid Haemorrhage
Q 2.19. Parenchymal Brain Haemorrhage
Q 2.18. Part 2 Cerebral Infarction – Diagnosis and Differential Diagnosis
Q 2.18. Part 1 Cerebral Infarction – Types and Warning Signs
Q 2.17. Asymptomatic Cerebrovascular Disease. Transient Ischemic Attacks.